Cargando…

Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy

Cell death markers, M65 and M30, have been suggested to be sensitive markers of liver inflammation and fibrosis in nonalcoholic fatty liver disease and chronic hepatitis C. Our aim was to investigate whether these markers were useful in diagnosing liver inflammation and fibrosis in chronic hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xinhuan, Wei, Hongshan, Lin, Wei, Hu, Zhongjie, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440132/ https://www.ncbi.nlm.nih.gov/pubmed/28514295 http://dx.doi.org/10.1097/MD.0000000000006807

Ejemplares similares

Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease
por: Li, Qiang, et al.
Publicado: (2020)

Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases
por: Deng, Yong-Qiong, et al.
Publicado: (2015)

Red Blood Cell Distribution Width Levels Correlate With Liver Fibrosis and Inflammation: A Noninvasive Serum Marker Panel to Predict the Severity of Fibrosis and Inflammation in Patients With Hepatitis B
por: Xu, Wen-Shen, et al.
Publicado: (2015)

Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy
por: Martin-Rodriguez, Jose Luis, et al.
Publicado: (2017)

Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury
por: Liu, Yiqi, et al.
Publicado: (2020)

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease
por: Takata, Ryo, et al.
Publicado: (2017)

Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
por: Wang, Lingmei, et al.
Publicado: (2020)

Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C
por: Chen, Sheng-Hung, et al.
Publicado: (2016)

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study
por: Borssén, Åsa D., et al.
Publicado: (2017)

Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
por: Yan, Li-Ting, et al.
Publicado: (2020)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Prognostic risk factors for patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids
por: Du, Xiaofei, et al.
Publicado: (2023)

Diagnostic Accuracy of Serum Procalcitonin for Spontaneous Bacterial Peritonitis Due to End-stage Liver Disease: A Meta-analysis
por: Yang, Yongtao, et al.
Publicado: (2015)

Diagnostic accuracy of ultrasound superb microvascular imaging for focal liver lesions: A protocol for systematic review and meta-analysis
por: Sui, Ping, et al.
Publicado: (2021)

Diagnostic accuracy of three-dimensional contrast-enhanced ultrasound for focal liver lesions: A protocol for systematic review and meta-analysis
por: Qu, Meijng, et al.
Publicado: (2021)

Elevated procalcitonin levels in primary hepatic neuroendocrine carcinoma: Case report and literature review
por: Han, Xiangjun, et al.
Publicado: (2020)

Hematological indices as indicators of silent inflammation in achalasia patients: A cross-sectional study
por: López-Verdugo, Fidel, et al.
Publicado: (2020)

Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational study
por: Nozaki, Akito, et al.
Publicado: (2021)

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

Metabolic status indicators and influencing factors in non-obese, non-centrally obese nonalcoholic fatty liver disease
por: Huang, Zhipeng, et al.
Publicado: (2023)

Cytopathological Analysis of Cyst Fluid Enhances Diagnostic Accuracy of Mucinous Pancreatic Cystic Neoplasms
por: Utomo, Wesley K., et al.
Publicado: (2015)

Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms
por: Xu, Ming-ming, et al.
Publicado: (2017)

The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis
por: Chen, Tiantian, et al.
Publicado: (2020)

Congenital hepatic fibrosis and coexistent retinal macular degeneration: A case report
por: Li, Dezhao, et al.
Publicado: (2019)

Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis
por: Fujinaga, Yukihisa, et al.
Publicado: (2021)

Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method
por: Yu, Zhe, et al.
Publicado: (2023)

Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma
por: Xie, Junhao, et al.
Publicado: (2021)

Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis
por: Zhang, Tianyao, et al.
Publicado: (2019)

Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI)
por: Wan, Minjie, et al.
Publicado: (2021)

Autophagy in hepatic macrophages can be regulator and potential therapeutic target of liver diseases: A review
por: Ge, Jun, et al.
Publicado: (2023)

A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
por: Zhang, Kang-Ling, et al.
Publicado: (2021)

Incidence and predictors for abnormal liver function during direct-acting antiviral agents in chronic hepatitis C patients
por: Liu, Yen-Chun, et al.
Publicado: (2020)

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Deng, Han, et al.
Publicado: (2015)

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Screening for microRNA-based diagnostic markers in hepatic alveolar echinococcosis
por: Ren, Bin, et al.
Publicado: (2019)

Knowledge, attitude, and behaviors toward liver health and viral hepatitis-related liver diseases in Thailand
por: Phisalprapa, Pochamana, et al.
Publicado: (2021)

A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease
por: Peng, Kaili, et al.
Publicado: (2021)

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Prognostic study of acute-on-chronic liver failure patients: Usefulness of the fibrosis-4 index
por: Watanabe, Yusuke, et al.
Publicado: (2022)

Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer
por: Long, Di, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cu20ncjg4bic651t20jfj977j6